1. Home
  2. RCUS vs PPTA Comparison

RCUS vs PPTA Comparison

Compare RCUS & PPTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$22.00

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Perpetua Resources Corp.

PPTA

Perpetua Resources Corp.

HOLD

Current Price

$32.24

Market Cap

2.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
PPTA
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.9B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
RCUS
PPTA
Price
$22.00
$32.24
Analyst Decision
Buy
Strong Buy
Analyst Count
9
3
Target Price
$28.89
$27.50
AVG Volume (30 Days)
1.6M
1.9M
Earning Date
02-24-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$240,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.50
$7.81
52 Week High
$26.40
$32.68

Technical Indicators

Market Signals
Indicator
RCUS
PPTA
Relative Strength Index (RSI) 47.16 70.59
Support Level $20.59 $30.54
Resistance Level $23.40 $32.50
Average True Range (ATR) 1.39 1.52
MACD -0.07 0.48
Stochastic Oscillator 32.38 94.35

Price Performance

Historical Comparison
RCUS
PPTA

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About PPTA Perpetua Resources Corp.

Perpetua Resources Corp is focused on the exploration, site restoration, and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Project is one of the highest-grade, open-pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. It has one segment, mineral exploration in the United States.

Share on Social Networks: